Editorial: Role of hypoxia- inducible factors in metabolic immune cell adaptation during sepsis In collaboration with Prof. Leon Nicolas Schulte from the German Center for Lung Research in Giessen, Germany and my dear colleague Prof. Eduardo López-Collazo from the TumourImmunology Laboratory at IdiPAZ in Madrid, we have edited a research topic focused on the role…
Fundación Familia Alonso will fund our laboratory. Fundación Familia Alonso has awarded our laboratory with a grant to address new therapies for the treatment of Cystic Fibrosis in pediatric patients. Cystic fibrosis is a genetic disorder mainly affecting the lungs because of the accumulation of mucus, generating recurrent infections. The aim of this…
University Hospital La Paz has been scored as the first hospital in Spain in the ranking of the best hospitals of Newsweek magazine. Newsweek magazine has published the ranking of the 250 best hospitals of the year 2023. University Hospital La Paz is the first in Spain in this ranking, that has analyzed hospitals from…
7 de febrero de 2023 La sede de Madrid de la Asociación Española Contra el Cáncer hace entrega de sus ayudas a la investigación en cáncer.
La inmunoterapia es un tipo de tratamiento contra el cáncer mediante el cual se intenta activar a nuestro sistema inmune, a “nuestras propias defensas”, contra el cáncer.
ntravesical BCG is the gold-standard therapy for non-muscle invasive bladder cancer (NMIBC)
Lung cancer (LC) continues to be the leading cause of cancer-related deaths in both men and women worldwide.
The C-type lectin receptor Dectin-1 was originally described as the β-glucan receptor expressed in myeloid cells, with crucial functions in antifungal responses.
We have analyzed BNT162b2 vaccine-induced immune responses in naive subjects and individuals recovered from coronavirus disease 2019 (COVID-19), both soon after (14 days) and later after (almost 8 months) vaccination.